Johnson Matthey PLC (LON:JMAT – Get Free Report) insider Richard Pike acquired 14 shares of the stock in a transaction that occurred on Wednesday, June 10th. The stock was purchased at an average price of GBX 1,990 per share, with a total value of £278.60.
Richard Pike also recently made the following trade(s):
- On Wednesday, May 13th, Richard Pike bought 10 shares of Johnson Matthey stock. The shares were bought at an average price of GBX 2,158 per share, with a total value of £215.80.
Johnson Matthey Stock Performance
JMAT traded up GBX 16 during trading hours on Monday, reaching GBX 2,082. The company’s stock had a trading volume of 33,354,254 shares, compared to its average volume of 2,908,089. The company has a debt-to-equity ratio of 69.69, a quick ratio of 0.76 and a current ratio of 1.56. The firm has a market cap of £3.49 billion, a PE ratio of -36.40, a price-to-earnings-growth ratio of 49,242.50 and a beta of 0.93. The company’s 50-day moving average is GBX 2,079.08 and its 200-day moving average is GBX 2,108.85. Johnson Matthey PLC has a 52 week low of GBX 1,674 and a 52 week high of GBX 2,434.
Wall Street Analyst Weigh In
A number of equities analysts recently commented on the company. Jefferies Financial Group reaffirmed a “restricted” rating on shares of Johnson Matthey in a research note on Friday, May 29th. UBS Group reissued a “neutral” rating and issued a GBX 2,200 price objective on shares of Johnson Matthey in a research report on Friday, May 22nd. Deutsche Bank Aktiengesellschaft upped their target price on Johnson Matthey from GBX 2,120 to GBX 2,400 and gave the stock a “buy” rating in a research note on Friday, May 29th. Finally, Berenberg Bank upped their target price on Johnson Matthey from GBX 2,100 to GBX 2,300 and gave the stock a “buy” rating in a research note on Monday, June 1st. Three research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of GBX 2,298.33.
View Our Latest Report on Johnson Matthey
About Johnson Matthey
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources. Today more than 13,000 Johnson Matthey professionals collaborate with their network of customers and partners to make a real difference to the world around us.
Featured Stories
- Five stocks we like better than Johnson Matthey
- Summer Is Coming–But There’s No End in Sight for This Crypto Winter
- Oil Could Dip, But These 3 Energy Stocks Still Look Built to Win
- What’s Behind the Social Media Controversy Surrounding IonQ?
- 3 Long-Duration Treasury ETFs to Watch if Rates Fall
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.
